Skip to content

Insider · CIK 0001315797

Satter Muneer A

Reports to the SEC for 9 companies · BRISBANE, CA

Transactions

50

Companies

9

Filings

14

CIK

0001315797

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2026-06-11ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2026-05-28ANNXAnnexon, Inc.P Purchase+$3.32M
2025-11-21ANNXAnnexon, Inc.P Purchase+$1.81M
2025-11-20ANNXAnnexon, Inc.P Purchase+$1.79M
2025-11-19ANNXAnnexon, Inc.P Purchase+$1.97M
2025-11-18ANNXAnnexon, Inc.P Purchase+$1.59M
2025-11-17ANNXAnnexon, Inc.P Purchase+$1.5M
2025-06-05ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2024-06-05ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2023-12-26ANNXAnnexon, Inc.P Purchase+$1.01M
2023-06-08ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2023-02-10ANNXAnnexon, Inc.P Purchase+$18M
2022-07-07ANNXAnnexon, Inc.P Purchase+$9.42M
2022-07-07ANNXAnnexon, Inc. · Warrants (Right to Buy)P Purchase+$76.7K
2022-06-09ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2021-06-02ANNXAnnexon, Inc. · Stock Option (Right to Buy)A Award—
2021-01-08RNTXRein Therapeutics, Inc.P Purchase+$9.9M
2020-07-28ANNXAnnexon, Inc.C Conversion—
2020-07-28ANNXAnnexon, Inc.P Purchase+$3.4M
2020-07-28ANNXAnnexon, Inc. · Series A-1 Preferred StockC Conversion—
2020-07-28ANNXAnnexon, Inc. · Series B Preferred StockC Conversion—
2020-07-28ANNXAnnexon, Inc. · Series C Preferred StockC Conversion—
2020-07-28ANNXAnnexon, Inc. · Series D Preferred StockC Conversion—
2020-06-08RNTXRein Therapeutics, Inc.P Purchase+$4.07M
2019-06-18WHWKWhitehawk Therapeutics, Inc. · Stock Option (Right to Buy)A Award—
2019-01-10WHWKWhitehawk Therapeutics, Inc.P Purchase+$58.4K
2019-01-09WHWKWhitehawk Therapeutics, Inc.P Purchase+$47.9K
2019-01-08WHWKWhitehawk Therapeutics, Inc.P Purchase+$44K
2019-01-07WHWKWhitehawk Therapeutics, Inc.P Purchase+$43.6K
2019-01-04WHWKWhitehawk Therapeutics, Inc.P Purchase+$42.4K
2019-01-03WHWKWhitehawk Therapeutics, Inc.P Purchase+$41.5K
2019-01-02WHWKWhitehawk Therapeutics, Inc.P Purchase+$38.8K
2018-12-31WHWKWhitehawk Therapeutics, Inc.P Purchase+$34.9K
2018-12-28WHWKWhitehawk Therapeutics, Inc.P Purchase+$34.4K
2018-12-27WHWKWhitehawk Therapeutics, Inc.P Purchase+$33.4K
2018-12-26WHWKWhitehawk Therapeutics, Inc.P Purchase+$33.9K
2018-12-21WHWKWhitehawk Therapeutics, Inc.P Purchase+$36.9K
2018-12-20WHWKWhitehawk Therapeutics, Inc.P Purchase+$37K
2018-12-19WHWKWhitehawk Therapeutics, Inc.P Purchase+$38.4K
2018-12-18WHWKWhitehawk Therapeutics, Inc.P Purchase+$39.9K
2018-12-14WHWKWhitehawk Therapeutics, Inc.P Purchase+$40.1K
2018-12-13WHWKWhitehawk Therapeutics, Inc.P Purchase+$40.3K
2018-12-12WHWKWhitehawk Therapeutics, Inc.P Purchase+$40.9K
2018-12-11WHWKWhitehawk Therapeutics, Inc.P Purchase+$41.8K
2018-12-10WHWKWhitehawk Therapeutics, Inc.P Purchase+$42.6K
2018-12-07WHWKWhitehawk Therapeutics, Inc.P Purchase+$42.8K
2018-12-06WHWKWhitehawk Therapeutics, Inc.P Purchase+$43.6K
2018-12-04WHWKWhitehawk Therapeutics, Inc.P Purchase+$42K
2018-12-03WHWKWhitehawk Therapeutics, Inc.P Purchase+$39.8K
2018-11-30WHWKWhitehawk Therapeutics, Inc.P Purchase+$39.7K